About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2011 (2011), Article ID 219060, 11 pages
http://dx.doi.org/10.1155/2011/219060
Research Article

Investigation of Hepatoprotective Activity of Induced Pluripotent Stem Cells in the Mouse Model of Liver Injury

1Institute of Pharmacology, National Yang-Ming University, No. 155, Section 2, Linong Street, Taipei 11221, Taiwan
2Division of Urology, Department of Surgery, Taipei Veterans General Hospital and Su-Ao & Yuan-Shan Branch, No. 201, Section 2, Shih-Pai Road, Taipei 11217, Taiwan
3School of Medicine, National Yang-Ming University, No. 155, Section 2, Linong Street, Taipei 11221, Taiwan
4Division of General Medicine, Taipei Veterans General Hospital, No. 201, Section 2, Shih-Pai Road, Taipei 11217, Taiwan
5Division of Gastroenterology, Taipei Veterans General Hospital, No. 201, Section 2, Shih-Pai Road, Taipei 11217, Taiwan
6Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, No. 201, Section 2, Shih-Pai Road, Taipei 11217, Taiwan
7Graduate Institute of Pharmacy, National Defense Medical Center, No. 161, Section 6, Minquan E. Road, Taipei 11490, Taiwan
8Department of Medical Research & Education, Taipei Veterans General Hospital, No. 201, Section 2, Shih-Pai Road, Taipei 11217, Taiwan

Received 5 April 2011; Accepted 27 May 2011

Academic Editor: Ken-ichi Isobe

Copyright © 2011 Chih-Hung Chiang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Chieli and G. Malvaldi, “Role of the microsomal fad-containing monooxygenase in the liver toxicity of thioacetamide S-oxide,” Toxicology, vol. 31, no. 1, pp. 41–52, 1984. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Pallottini, C. Martini, A. M. Bassi, P. Romano, G. Nanni, and A. Trentalance, “Rat HMGCoA reductase activation in thioacetamide-induced liver injury is related to an increased reactive oxygen species content,” Journal of Hepatology, vol. 44, no. 2, pp. 368–374, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Shapiro, M. Ashkenazi, N. Weizman, M. Shahmurov, H. Aeed, and R. Bruck, “Curcumin ameliorates acute thioacetamide-induced hepatotoxicity,” Journal of Gastroenterology and Hepatology, vol. 21, no. 2, pp. 358–366, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. B. K. Gunawan, Z. X. Liu, D. Han, N. Hanawa, W. A. Gaarde, and N. Kaplowitz, “c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity,” Gastroenterology, vol. 131, no. 1, pp. 165–178, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. A. P. Margeli, L. Papadimitriou, S. Ninos, E. Manolis, M. G. Mykoniatis, and S. E. Theocharis, “Hepatic stimulator substance administration ameliorates liver regeneration in an animal model of fulminant hepatic failure and encephalopathy,” Liver International, vol. 23, no. 3, pp. 171–178, 2003. View at Scopus
  6. B. L. Blitzer, J. G. Waggoner, and E. A. Jones, “A model of fulminant hepatic failure in the rabbit,” Gastroenterology, vol. 74, no. 4, pp. 664–671, 1978.
  7. M. E. Horowitz, D. F. Schafer, and P. Molnar, “Increased blood-brain transfer in a rabbit model of acute liver failure,” Gastroenterology, vol. 84, no. 5, pp. 1003–1011, 1983.
  8. N. Selzner, D. R. Grant, I. Shalev, and G. A. Levy, “The immunosuppressive pipeline: meeting unmet needs in liver transplantation,” Liver Transplantation, vol. 16, no. 12, pp. 1359–1372, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Lumelsky, O. Blondel, P. Laeng, I. Velasco, R. Ravin, and R. McKay, “Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets,” Science, vol. 292, no. 5520, pp. 1389–1394, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. E. A. Jones, D. Tosh, D. I. Wilson, S. Lindsay, and L. M. Forrester, “Hepatic differentiation of murine embryonic stem cells,” Experimental Cell Research, vol. 272, no. 1, pp. 15–22, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Kumashiro, K. Asahina, R. Ozeki et al., “Enrichment of hepatocytes differentiated from mouse embryonic stem cells as a transplantable source,” Transplantation, vol. 79, no. 5, pp. 550–557, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Yamamoto, G. Quinn, A. Asari et al., “Differentiation of embryonic stem cells into hepatocytes: biological functions and therapeutic application,” Hepatology, vol. 37, no. 5, pp. 983–993, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Heo, V. M. Factor, T. Uren et al., “Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver,” Hepatology, vol. 44, no. 6, pp. 1478–1486, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. N. D. Theise, M. Nimmakayalu, R. Gardner et al., “Liver from bone marrow in humans,” Hepatology, vol. 32, no. 1, pp. 11–16, 2000. View at Scopus
  15. M. R. Alison, R. Poulsom, R. Jeffery et al., “Hepatocytes from non-hepatic adult stem cells,” Nature, vol. 406, no. 6793, p. 257, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. F. P. Russo, M. R. Alison, B. W. Bigger et al., “The bone marrow functionally contributes to liver fibrosis,” Gastroenterology, vol. 130, no. 6, pp. 1807–1821, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Takahashi and S. Yamanaka, “Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors,” Cell, vol. 126, no. 4, pp. 663–676, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Okita, T. Ichisaka, and S. Yamanaka, “Generation of germline-competent induced pluripotent stem cells,” Nature, vol. 448, no. 7151, pp. 313–317, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Yamanaka, “A fresh look at iPS cells,” Cell, vol. 137, no. 1, pp. 13–17, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Si-Tayeb, F. K. Noto, M. Nagaoka et al., “Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells,” Hepatology, vol. 51, no. 1, pp. 297–305, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Sancho-Bru, P. Roelandt, N. Narain et al., “Directed differentiation of murine-induced pluripotent stem cells to functional hepatocyte-like cells,” Journal of Hepatology, vol. 54, no. 1, pp. 98–107, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. Song, J. Cai, Y. Liu et al., “Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells,” Cell Research, vol. 19, no. 11, pp. 1233–1242, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. T. C. Jeong, H. K. Gu, J. I. Park et al., “Pretreatment of male BALB/c mice with β-ionone potentiates thioacetamide-induced hepatotoxicity,” Toxicology Letters, vol. 105, no. 1, pp. 39–46, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Hayase, Y. Yamamoto, K. Yamamoto, H. Abiru, Y. Nishitani, and Y. Fukui, “Relationship between cocaine-induced hepatotoxic neurobehavioral and biochemical changes in mice: the antidotal effects of buprenorphine,” Life Sciences, vol. 67, no. 1, pp. 45–52, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. S. H. Gammal, A. S. Basile, D. Geller, P. Skolnick, and E. A. Jones, “Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands,” Hepatology, vol. 11, no. 3, pp. 371–378, 1990. View at Scopus
  26. J. Ribeiro, B. Nordlinger, F. Ballet et al., “Intrasplenic hepatocellular transplantation corrects hepatic encephalopathy in portacaval-shunted rats,” Hepatology, vol. 15, no. 1, pp. 12–18, 1992. View at Scopus
  27. H. Yagi, A. Soto-Gutierrez, B. Parekkadan et al., “Mesenchymal stem cells: mechanisms of immunomodulation and homing,” Cell Transplantation, vol. 19, no. 6-7, pp. 667–679, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. T. K. Kuo, S. P. Hung, C. H. Chuang et al., “Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells,” Gastroenterology, vol. 134, no. 7, pp. 2111–e3, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. H. K. Väänänen, “Mesenchymal stem cells,” Annals of Medicine, vol. 37, no. 7, pp. 469–479, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Cancedda, G. Bianchi, A. Derubeis, and R. Quarto, “Cell therapy for bone disease: a review of current status,” Stem Cells, vol. 21, no. 5, pp. 610–619, 2003. View at Scopus
  31. S. V. Tokalov, S. Grüner, S. Schindler, G. Wolf, M. Baumann, and N. Abolmaali, “Age-related changes in the frequency of mesenchymal stem cells in the bone marrow of rats,” Stem Cells and Development, vol. 16, no. 3, pp. 439–446, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. M. R. Alison, R. Poulsom, R. Jeffery et al., “Hepatocytes from non-hepatic adult stem cells,” Nature, vol. 406, no. 6793, p. 257, 2000. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Moretti, M. Bellin, A. Welling et al., “Patient-specific induced pluripotent stem-cell models for long-QT syndrome,” The New England Journal of Medicine, vol. 363, no. 15, pp. 1397–1409, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Taura, M. Sone, K. Homma et al., “Induction and isolation of vascular cells from human induced pluripotent stem cells—brief report,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 7, pp. 1100–1103, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Karumbayaram, B. G. Novitch, M. Patterson et al., “Directed differentiation of human-induced pluripotent stem cells generates active motor neurons,” Stem Cells, vol. 27, no. 4, pp. 806–811, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. S. J. Chen, C. M. Chang, S. K. Tsai et al., “Functional improvement of focal cerebral ischemia injury by subdural transplantation of induced pluripotent stem cells with fibrin glue,” Stem Cells and Development, vol. 19, no. 11, pp. 1757–1767, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Miura, Y. Okada, T. Aoi et al., “Variation in the safety of induced pluripotent stem cell lines,” Nature Biotechnology, vol. 27, no. 8, pp. 743–745, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. C. E. Pasi, A. Dereli-Öz, S. Negrini et al., “Genomic instability in induced stem cells,” Cell Death and Differentiation, vol. 18, no. 5, pp. 745–753, 2011. View at Publisher · View at Google Scholar